ARYL-S(O)N-SUBSTITUTED CARBOXYLIC-HYDROXAMIC ACIDS AND METHOD OF THEIR SYNTHESIS Russian patent published in 2001 - IPC

Abstract RU 2175316 C2

FIELD: organic chemistry, chemical technology. SUBSTANCE: invention relates to novel aryl-S(O)n-substituted carboxylic/hydroxamic acids of the formula (I) where Y means hydroxy-group, XONH- where X means H, C1-C6-alkyl; R1 means H, C1-C6-alkyl; R2 means H, C1-C6-alkyl, C3-C8-cycloalkyl; C3-C8-cycloalkyl-C2-C8-alkyl, tetrahydropyranyl, piperidinyl, -NR6R7 where R6 means H, C1-C6-alkyl, aryl; R7 means H, C1-C6-alkyl, aryl, aryl-C1-C8-alkyl, -SO2NR8R9, arylhydroxycarbonyl, C1-C8-alkoxycarbonyl, -C(O)-O-CH2Rd where Rd means phenyl; or group NR6R7 means valineamido-group; R8 and R9 mean independently H, C1-C6-alkyl; or R1 and R2 in common with carbon atom to which they are bound form C3-C8-cycloalkyl or possibly piperidinyl or tetrahydropyranyl substituted with lower alkyl; R3 means H, C1-C6-alkyl, C3-C8-cycloalkyl, C3-C8-cycloalkyl-C1-C8-alkyl, aryl, aryl-C1-C8-alkyl, piperidinyl, tetrahydropyranyl; R4 means H, C1-C6/ -alkyl, C3-C8-cycloalkyl, C3-C8-cycloalkyl-C1-C8-alkyl; R2 and R3 in common mean C3-C8-cycloalkyl; R3 and R4 in common mean C3-C8-cycloalkyl; R5 means possibly substituted aryl. Compounds of the formula (I) inhibit activity of matrix proteases that ensures to use their in pharmaceutical composition in effective doses. EFFECT: improved synthesis. 28 cl, 2 tbl, 48 ex

Similar patents RU2175316C2

Title Year Author Number
HYDROXAMIC ACID DERIVATIVES, METHOD OF THEIR SYNTHESIS, DRUG AND METHOD OF ITS PREPARING 1995
  • Majkl Dzhon Brodkhurst
  • Pol' Ehntoni Braun
  • Vil'Jam Genri Dzhonson
RU2131425C1
3-OXO-3,9-DIHYDRO-1H-CHROMENO[2,3-c] PYRROLES AS GLUCOKINASE ACTIVATORS 2011
  • Sarabu Ramakantkh
RU2603191C2
TRIAZOLO (4,3-a) 1,4 BENZO DIAZEPINES AND THRENO (3,2 1992
  • Armin Valzer[Ch]
RU2094436C1
PYRAZOLEPYRIMIDINES 2005
  • Din Tsintsze
  • Tszjan Nan'
  • Roberts Dzhon Loson
RU2412186C2
FLUORO-SUBSTITUTED 2-OXO-AZEPANE DERIVATIVES 2006
  • Flor Aleksandr
  • Gallej Guido
  • Jakob-Roehtne Roland
  • Kitas Ehrik Argirios
  • Vostl' Vol'Fgang
RU2419611C2
PYRASOLBENZODIAZEPINES AS CDK2 INHIBITORS, SYNTHESIS INTERMEDIATES AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME 2000
  • Din Tsin'I
  • Lju Dzin'Jun'
  • Mehdison Vinsent Stjuart
  • Pitstsolato Dzhakomo
  • Vehj Chunchehn'
  • Vovkulich Piter Majkl
RU2249593C2
DERIVATIVES OF 3-β-ALKENYLPENAM AND THEIR PHARMACEUTICALLY COMPATIBLE SALTS 1994
  • Kristian Khubshverien
  • Khans Rikhter
  • Zhan-Ljuk Speklin
RU2139290C1
4-HYDROXYPIPERIDINE DERIVATIVES 1997
  • Aleksander Alanin
  • Bernd Bjuttel'Mann
  • Mari-Pol' Khajtts Najdkhart
  • Ehmmanjuehl' Pinar
  • Rene Viler
RU2178412C2
2-(ARYLPHENYL)-AMINOIMIDAZOLINE DERIVATIVES AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF 1998
  • Blej Kit Rodzher
  • Klark Robin Duglas
  • Dzhakhandzhir Alam
  • Koval'Chik Brjus Ehndrju
  • Lopez-Tapija Fransisko Khav'Er
  • Mjul'Dorf Aleksander Viktor
  • O'Jang Kounde
  • San Tomas Uajtao
RU2211834C2
INDOL-3-YL-CARBONYL-PIPERADINE-BENZIMIDAZOLE DERIVATIVES AS V1A RECEPTOR ANTAGONISTS 2006
  • Bissants Katerina
  • Grundshober Kristof
  • Ratni Khasan
  • Rodzhers-Ehvans Mark
  • Shnajder Patrik
RU2415139C2

RU 2 175 316 C2

Authors

Bender Stiven Li

Broka Kris Allen

Kehmpbell Dzheffri Allen

Kastelkhano Arlindo Lukas

Khendriks Robert Tehn

Sarma Keshab

Fisher Lourens Ehmerson

Dates

2001-10-27Published

1996-12-19Filed